Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
With
Aardex Pharmionic
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Postmenopausal women with hormone sensitive early breast cancer.
Documented decision of treatment with anastrozole which will start in 13 weeks according to current SmPC OR current treatment with anastrozole according to current SmPC, that has not exceeded thirteen weeks before enrollment.
Subjects who accept to use MEMS® monitors to automatically compile their drug dosing histories.
You may not be if
Concomitant or previous use of adjuvant tamoxifen, letrozole or exemestane for the current tumour.
Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff or staff at the study site).
Participation in another clinical study with an investigational product during the last 3 months.
Clareo Health | Arimidex Therapy Compliance Electronic Monitoring System
